Solara Active Pharma Sciences is an API and finished-dose manufacturer based in India. It holds 91 active US drug master files and 32 valid CEPs. Its GMP standing is certified by CDSCO (India), US FDA and EMA, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 6 February 2026 as VAI. Customs aggregates show $85.7M of exports covering 1,240 molecules to 62 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Anakapalli District, India | 3016965485 |
| Mysuru, India | 3011856449 |
| New Mangalore, India | 3008252997 |
| Chennai, India | Not on file |
| cuddalore 607 005, India | Not on file |
| Periyakalapet, India | 3002808058 |
6 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Ibuprofen | EDQM, SFDA (Saudi Arabia), US FDA | 9 |
| Mefenamic Acid | EDQM, US FDA | 4 |
| Colchicine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Dextromethorphan | EDQM, US FDA | 3 |
| Hydralazine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Levetiracetam | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Mycophenolic Acid | EDQM, US FDA | 3 |
| Succinylcholine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Aprepitant | EDQM, US FDA | 2 |
| Bumetanide | EDQM, US FDA | 2 |
| Buspirone | EDQM, US FDA | 2 |
| Celecoxib | EDQM, US FDA | 2 |
| Dipyridamole | EDQM, US FDA | 2 |
| Disulfiram | EDQM, US FDA | 2 |
| Etomidate | EDQM, US FDA | 2 |
| Flecainide | EDQM, US FDA | 2 |
| Gabapentin | EDQM, US FDA | 2 |
| Mesalazine | EDQM, US FDA | 2 |
| Mesna | EDQM, US FDA | 2 |
| Mirabegron | EDQM, US FDA | 2 |
| Mycophenolate Mofetil | EDQM, SFDA (Saudi Arabia) | 2 |
| Naproxen | US FDA | 2 |
| Nizatidine | EDQM, US FDA | 2 |
| Olanzapine | EDQM, US FDA | 2 |
| Oseltamivir | EDQM, US FDA | 2 |
| Praziquantel | EDQM, US FDA | 2 |
| Sevelamer | US FDA | 2 |
| Venlafaxine | EDQM, US FDA | 2 |
| Acitretin | US FDA | 1 |
| Acyclovir | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 2 | 5 |
| US FDA | None | 5 |
| EMA | None | 3 |
| MFDS (Korea) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $13.8M | 40 |
| 2025 | Not reported | $85.7M | 62 |
| 2024 | Not reported | $95.4M | 63 |
| 2023 | Not reported | $95.8M | 63 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Solara Active Pharma Sciences comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.